Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://barbaraepfe521794.eedblog.com/40843042/tirzepatide-a-new-frontier-in-diabetes-treatment